Yüklüyor......
N,N-Dimethylglycine in patients with progressive multiple sclerosis: result of a pilot double-blind, placebo, controlled randomized clinical trial
Oral administration of N,N-Dimethylglycine (DMG), a tertiary amino acid, presumably enhances oxygen utilization by tissue and complex with free radicals. Beneficial effects are improved endurance performance and reduction fatigue in humans and animals. This pilot study reports the results over a one...
Kaydedildi:
| Yayımlandı: | Neurol Res Pract |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BioMed Central
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8142643/ https://ncbi.nlm.nih.gov/pubmed/34024278 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s42466-021-00126-z |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|